Ken Griffin Dr Reddys Laboratories LTD Transaction History

Citadel Advisors LLC

$483 Billion
Q2 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Citadel Advisors LLC holds 6,000 shares of RDY stock, worth $470,340. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,000

Previous 5,700 5.26%

Holding current value

$470,340

Previous $418,000 9.33%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$68.26 - $76.19 $44,027 - $49,142	645 Added 9.17%	7,681 $585,000
Q1 2024 May 15, 2024	SELL	$67.36 - $77.59 $6.97 Million - $8.03 Million	-103,473 Reduced 93.63%	7,036 $516,000
Q4 2023 Feb 14, 2024	SELL	$64.27 - $69.9 $3.94 Million - $4.29 Million	-61,339 Reduced 35.69%	110,509 $7.69 Million
Q3 2023 Nov 14, 2023	SELL	$61.9 - $72.77 $7.72 Million - $9.08 Million	-124,770 Reduced 42.06%	171,848 $11.5 Million
Q2 2023 Aug 14, 2023	BUY	$53.34 - $63.11 $5.81 Million - $6.87 Million	108,869 Added 57.99%	296,618 $18.7 Million
Q1 2023 May 15, 2023	BUY	$51.63 - $56.93 $5.16 Million - $5.69 Million	99,886 Added 113.68%	187,749 $10.7 Million
Q4 2022 Feb 14, 2023	BUY	$51.15 - $57.45 $4.49 Million - $5.05 Million	87,863 New	87,863 $4.55 Million
Q2 2022 Aug 15, 2022	BUY	$49.62 - $58.13 $1.95 Million - $2.28 Million	39,262 Added 227.24%	56,540 $3.13 Million
Q1 2022 May 16, 2022	BUY	$48.27 - $65.25 $31,616 - $42,738	655 Added 3.94%	17,278 $963,000
Q3 2021 Nov 15, 2021	SELL	$60.19 - $75.29 $688,453 - $861,167	-11,438 Reduced 40.76%	16,623 $1.08 Million
Q2 2021 Aug 16, 2021	SELL	$62.12 - $74.2 $401,481 - $479,554	-6,463 Reduced 18.72%	28,061 $2.06 Million
Q1 2021 May 17, 2021	BUY	$57.98 - $73.08 $1.81 Million - $2.29 Million	31,274 Added 962.28%	34,524 $2.12 Million
Q4 2020 Feb 16, 2021	SELL	$62.61 - $71.29 $791,515 - $901,248	-12,642 Reduced 79.55%	3,250 $232,000
Q3 2020 Nov 16, 2020	BUY	$51.39 - $72.41 $316,408 - $445,828	6,157 Added 63.25%	15,892 $1.11 Million
Q2 2020 Aug 14, 2020	BUY	$39.55 - $54.65 $121,497 - $167,884	3,072 Added 46.11%	9,735 $516,000
Q1 2020 May 15, 2020	BUY	$34.75 - $45.85 $231,539 - $305,498	6,663 New	6,663 $269,000
Q4 2019 Feb 14, 2020	SELL	$36.66 - $41.78 $590,775 - $673,284	-16,115 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$34.82 - $39.26 $961,554 - $1.08 Million	-27,615 Reduced 63.15%	16,115 $610,000
Q2 2019 Aug 14, 2019	BUY	$36.05 - $42.76 $679,614 - $806,111	18,852 Added 75.78%	43,730 $1.64 Million
Q1 2019 May 15, 2019	BUY	$35.77 - $40.57 $591,063 - $670,378	16,524 Added 197.8%	24,878 $0
Q4 2018 Feb 14, 2019	SELL	$31.89 - $38.44 $1.78 Million - $2.14 Million	-55,694 Reduced 86.96%	8,354 $314,000
Q2 2018 Aug 10, 2018	BUY	$28.49 - $35.06 $1.6 Million - $1.96 Million	56,045 Added 700.3%	64,048 $0
Q3 2017 Nov 09, 2017	BUY	$30.11 - $37.72 $240,970 - $301,873	8,003	8,003 $286,000

Others Institutions Holding RDY

# of Institutions

233

Shares Held

24M

Call Options Held

14.6K

Put Options Held

2.8K

View Full List

About DR REDDYS LABORATORIES LTD

Ticker RDY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 166,028,992
Market Cap $13B
Description
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...

More about RDY

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account